Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary
vasculature, which is characterized by increased pulmonary artery pressure as a result of …

Background: Pulmonary arterial hypertension (PAH) is a debilitating chronic disorder of the
pulmonary vasculature characterized by elevated mean pulmonary arterial pressure, right …

Pulmonary arterial hypertension (PAH) is a life-threatening and progressive disease of
various origins characterized by pulmonary vascular remodeling that leads to increased …

Pulmonary arterial hypertension (PAH) is a disease characterized by an elevation in
pulmonary artery pressure that can lead to right ventricular failure and death. Conventional …

Pulmonary arterial hypertension (PAH) develops from an abnormal interaction between the
endothelium and smooth muscle cells in the pulmonary vasculature and is characterized by …

Pulmonary Arterial hypertension (PAH) is a chronic and progressive disease characterized
by an increase in pulmonary vascular resistance due to severe remodeling of the small …

Pulmonary arterial hypertension (PAH) is a disease characterized by an elevation in
pulmonary artery pressure that can lead to right ventricular failure and death. The pulmonary …

Pulmonary arterial hypertension (PAH) is a progressive disease characterised by
remodelling of small pulmonary arteries leading to an increased pulmonary vascular …

Pulmonary arterial hypertension (PAH) is characterized by vasoconstriction, in situ
thrombosis, and vascular remodeling of small pulmonary arteries inducing increased …

Since the innovation of epoprostenol, a prostacyclin analog, providing treatment for
pulmonary arterial hypertension (PAH) in the 1990s, two types of oral drugs, endothelin …